Publication Name	World Journal of Hepatology
Manuscript ID	13940
Country	Egypt

Received	2014-09-09 12:10
Peer-Review Started	2014-09-09 21:55
To Make the First Decision	2014-09-28 12:30
Return for Revision	2014-10-06 17:56
Revised	2015-07-29 00:00
Second Decision	2015-10-21 17:28
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-11-04 16:55
Articles in Press	2015-11-04 16:55
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-11-06 17:56
Publish the Manuscript Online	2015-11-18 11:12

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Hepatitis C virus: A global view
Manuscript Source	Invited Manuscript
All Author List	Amal Ahmed Mohamed, Tamer A Elbedewy, Magdy El-Serafy, Naglaa El-Toukhy, Wesam Ahmed and Zaniab Ali El Din
Funding Agency and Grant Number
Corresponding Author	Dr. Amal Ahmed Mohamed, Consultant of Biochemistry and Molecular Biology, Biochemistry Department, National Hepatology and Tropical Medicine Institute, Fom El-Khalig, Cairo 11796, Egypt. amalahmedhcp@yahoo.com
Key Words	Hepatitis C; Peginterferon; Sofosbuvir; Direct-acting antivirals
Core Tip	Peginterferon is responsible for many side effects. Direct-acting antiviral drugs represent a break-through in hepatitis C virus (HCV) therapy. Sofosbuvir is the first compound to enter the market with Pegin-terferon-free combination regimens. The next few years are expected to introduce more new drugs in the market of HCV therapy with complete elimination of pegylated interferon and ribavirin combination therapy.
Publish Date	2015-11-18 11:12
Citation	Mohamed AA, Elbedewy TA, El-Serafy M, El-Toukhy N, Ahmed W, Ali El Din Z. Hepatitis C virus: A global view. World J Hepatol 2015; 7(26): 2676-2680
URL	http://www.wjgnet.com/1948-5182/full/v7/i26/2676.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i26.2676

Full Article (PDF)	WJH-7-2676.pdf
Full Article (Word)	WJH-7-2676.doc
Manuscript File	13940-Review.docx
Answering Reviewers	13940-Answering reviewers.pdf
Audio Core Tip	13940-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	13940-Conflict-of-interest statement.pdf
Copyright License Agreement	13940-Copyright assignment.pdf
Peer-review Report	13940-Peer-review(s).pdf
Scientific Misconduct Check	13940-Scientific misconduct check.pdf
Scientific Editor Work List	13940-Scientific editor work list.pdf